BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31919532)

  • 1. [Locoregional and local ablative treatment options for liver tumors].
    Hinrichs JB; Wacker FK
    Internist (Berl); 2020 Feb; 61(2):158-163. PubMed ID: 31919532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regional therapy of liver tumors].
    Spangenberg HC; Mohr L; Blum HE
    Internist (Berl); 2007 Jan; 48(1):40-5. PubMed ID: 17160664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local and locoregional treatment of intrahepatic cholangiocarcinoma].
    Wacker F; Dewald C
    Radiologe; 2022 Mar; 62(3):247-252. PubMed ID: 34981129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Options in Patients Awaiting Liver Transplantation with Hepatocellular Carcinoma and Cholangiocarcinoma.
    Unzueta A; Cabrera R
    Clin Liver Dis; 2017 May; 21(2):231-251. PubMed ID: 28364811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional therapy for cholangiocarcinoma.
    Kuhlmann JB; Blum HE
    Curr Opin Gastroenterol; 2013 May; 29(3):324-8. PubMed ID: 23337933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional therapies for the treatment of primary and metastatic hepatic tumors: A disease-based review of techniques and critical appraisal of current evidence.
    Johnson BW; Wright GP
    Am J Surg; 2019 Mar; 217(3):541-545. PubMed ID: 30782316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablative technologies for hepatocellular, cholangiocarcinoma, and metastatic colorectal cancer of the liver.
    Hansen PD; Cassera MA; Wolf RF
    Surg Oncol Clin N Am; 2015 Jan; 24(1):97-119. PubMed ID: 25444471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous occurrence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in both lobes of the liver.
    Topaloğlu S; Sağlam K; Çalık A; Cobanoğlu Ü; Öztürk MH
    Turk J Gastroenterol; 2014 Apr; 25(2):209-11. PubMed ID: 25003684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approach to hepatocellular carcinoma: a difficult choice.
    Gennari L
    Ann Ital Chir; 2008; 79(2):79-80. PubMed ID: 18727268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local ablation of malignant lesions of the liver - potential applications and limitations of the different methods].
    Zuber-Jerger I; Geissler M; Spangenberg HC; Mohr L; Weizsäcker F; Blum HE
    Z Gastroenterol; 2004 Jan; 42(1):31-8. PubMed ID: 14997401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of tumor response on MR imaging after locoregional therapy.
    Vossen JA; Buijs M; Kamel IR
    Tech Vasc Interv Radiol; 2006 Sep; 9(3):125-32. PubMed ID: 17561215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for transplantation and bridging procedures for primary hepatobiliary malignancies].
    Mittler J; Heinrich S; Lang H
    Chirurg; 2018 Nov; 89(11):865-871. PubMed ID: 30238348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter CT arterial portography and CT hepatic arteriography for liver tumor visualization during percutaneous ablation.
    van Tilborg AA; Scheffer HJ; Nielsen K; van Waesberghe JH; Comans EF; van Kuijk C; van den Tol PM; Meijerink MR
    J Vasc Interv Radiol; 2014 Jul; 25(7):1101-1111.e4. PubMed ID: 24755086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary Liver Cancers - Hepatocellular Carcinoma and Cholangiocarcinoma].
    Soysal SD; Kollmar O
    Ther Umsch; 2021; 78(10):585-588. PubMed ID: 34844438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports.
    Carvalho VO; Galastri FL; Affonso BB; Falsarella PM; Valle LGM; Ferraz-Neto BH; Rezende MB; Motta-Leal-Filho JMD; Garcia RG; Nasser F
    Einstein (Sao Paulo); 2020; 18():eRC4990. PubMed ID: 32130329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current role of portal vein embolization/hepatic artery chemoembolization.
    Kokudo N; Makuuchi M
    Surg Clin North Am; 2004 Apr; 84(2):643-57. PubMed ID: 15062666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatobiliary cancers, version 2.2014.
    Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
    J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interventional radiology in the treatment of intrahepatic cholangiocarcinoma.
    Ierardi AM; Angileri SA; Patella F; Panella S; Lucchina N; Petre EN; Pinto A; Franceschelli G; Carrafiello G; Cornalba G; Sofocleous CT
    Med Oncol; 2017 Jan; 34(1):11. PubMed ID: 28008570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of bile peritonitis caused by jejunal perforation after radiofrequency ablation for the multiple liver metastases from cholangiocarcinoma successfully treated with various interventional radiological procedures after pancreatoduodenectomy].
    Yasumoto T; Shimizu J; Watanabe N; Inada M; Nakata S; Sato M; Hayashi S; Dono K; Kitada M; Shimano T
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2093-5. PubMed ID: 20037334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.